Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.35 (8.14%)
Bid:
4.65
Ask:
4.80
Spread: 0.15 (3.226%)
Market Cap: £40.44m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

Form 8.5 (EPT/RI)

29 May 2025 10:16

RNS Number : 6119K
Panmure Liberum Limited
29 May 2025
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Liberum Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Revolution Beauty Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Revolution Beauty Group plc

(d) Date dealing undertaken:

28 May 2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

Purchase

62,892

0.07 GBP

0.068 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

29/05/2025

Contact name:

Rosie Kinsella

Telephone number:

+44 (0)207 886 2574

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERMZGZKLLKGKZG
Date   Source Headline
7th Mar 20252:47 pmRNSHolding(s) in Company
28th Feb 20253:08 pmRNSTotal Voting Rights
24th Feb 20258:52 amRNSHolding(s) in Company
21st Feb 20251:50 pmRNSHolding(s) in Company
31st Jan 20257:00 amRNSTotal Voting Rights
29th Jan 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jan 20252:24 pmRNSHolding(s) in Company
23rd Jan 202510:44 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSFY25 Trading Update
2nd Jan 20257:00 amRNSUpdate on claim alleged by Chrysalis Investments
2nd Jan 20257:00 amRNSTotal Voting Rights
27th Dec 202411:54 amRNSHolding(s) in Company
13th Dec 20241:05 pmRNSHolding(s) in Company
12th Dec 202410:42 amRNSHolding(s) in Company
11th Dec 20243:15 pmRNSHolding(s) in Company
2nd Dec 20243:25 pmRNSTotal Voting Rights
2nd Dec 20243:24 pmRNSHolding(s) in Company
19th Nov 20247:00 amRNSInterim Results
8th Nov 20247:00 amRNSNotice of HY25 Results
4th Nov 20247:00 amRNSNominated Adviser and Broker
4th Nov 20247:00 amRNSTotal Voting Rights
9th Oct 20247:00 amRNSHY2025 Trading Update
7th Oct 202412:40 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSRelated party transactions
5th Sep 20244:56 pmRNSHolding(s) in Company
30th Aug 20244:11 pmRNSHolding(s) in Company
30th Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20244:59 pmRNSAnnual General Meeting
29th Jul 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Jul 20247:00 amRNSNotice of Retail Investor Presentation
3rd Jul 20245:00 pmRNSNotice of AGM and posting of Annual Report
1st Jul 202412:00 pmRNSTotal Voting Rights and NOMAD name change
26th Jun 20247:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 29 FEBRUARY 2024
17th Jun 20247:00 amRNSNotice of FY24 Results
30th Apr 20244:59 pmRNSTotal Voting Rights
29th Apr 20247:00 amRNSHolding(s) in Company
22nd Apr 20249:09 amRNSResponse to allegations by Chrysalis Investments
12th Apr 20244:43 pmRNSHolding(s) in Company
4th Apr 20247:01 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSHolding(s) in Company
3rd Apr 20249:40 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSTrading Update
11th Mar 20241:50 pmRNSTotal Voting Rights
20th Feb 20247:00 amRNSGrant of Share Options
19th Feb 20247:00 amRNSChange of Auditor
8th Feb 20247:00 amRNSCapital Markets Event and FY24 Trading Update
5th Feb 20247:00 amRNSAdam Minto Settlement Agreement
2nd Feb 20247:00 amRNSResponse to allegations by Chrysalis Investments
26th Jan 20247:00 amRNSBlock Admission Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.